2-year, firm-fixed price (FFP) hybrid task order for professional and technical support services to support the office of policy (OP) and the office of product evaluation and quality (opeq) within the…
Active Awarded Last action
- Contract number
- 75F40126F19023
- Awardee
-
Kaiva Strategies, LLC UEI HCWKVFGBPA64
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $1,098,371
Award facts
- Contract value 49% obligated
-
- $1,098,370.56 Current, with exercised options
- $2,229,401.08 Potential, with all options
- Completion date 7% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541611 Administrative Management and General Management Consulting Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- Competitive 8(a)
- Competition
- Full and Open Competition after exclusion of sources Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Silver Spring, MD 20993, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this award
The Food and Drug Administration issued a $2.23 million delivery order to Kaiva Strategies, LLC, a tribally-owned, minority-owned 8(a) small business, on August 27, 2026, under the Competitive 8(a) Professional, Administrative, and Consulting Services (PACS) IDIQ. The order is a two-year firm-fixed-price hybrid task order providing professional and technical support services to FDA's Office of Policy and Office of Product Evaluation and Quality within the Center for Devices and Radiological Health, with an ultimate completion date of August 26, 2028.
Place of performance is Silver Spring, MD. The PACS IDIQ is a $100 million Competitive 8(a) single-award vehicle running through August 2028 supporting professional, administrative, and consulting services across FDA. Kaiva Strategies operates primarily as a managed service delivery vehicle; across its SCI-reportable prime contracts, subcontractors performed an average of 70 percent of contractor hours.
Description
2-year, firm-fixed price (FFP) hybrid task order for professional and technical support services to support the office of policy (OP) and the office of product evaluation and quality (opeq) within the FDA's center for devices and radiological he
Quick answers
Who was awarded contract 75F40126F19023?
75F40126F19023 was awarded to Kaiva Strategies, LLC by Food and Drug Administration (Department of Health and Human Services) on August 27, 2026.
How much is contract 75F40126F19023 worth?
The government has obligated $1,098,371 on 75F40126F19023. Its potential value, with all options, is $2,229,401.
Is contract 75F40126F19023 an order under another contract?
Yes. 75F40126F19023 is a delivery order under 75F40123D00021, an indefinite delivery contract.
Was contract 75F40126F19023 competed?
The extent of competition for 75F40126F19023 was full and open competition after exclusion of sources. It was set aside: Competitive 8(a).
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award